Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19409636.
- Also identified by DOI 10.1016/j.radonc.2009.04.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report on 14 patients treated with linac- or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrence from prostate cancer, up to the mean dose of 30Gy/3 fractions. At the mean follow-up of 18.6months, five patients experienced clinical out-field progression. Toxicity was minimal. Further investigation is warranted in order to identify the patients that benefit most from this treatment modality and to define the optimal association of such local approach with androgen deprivation. Hopefully, effective local therapy might reduce the burden of systemic therapies given to the recurrent/metastatic prostate cancer patients.
Medical subject headings
- Lymph Nodes
- Neoplasm Recurrence, Local
- Prostatic Neoplasms
- Radiosurgery
- Radiotherapy Planning, Computer-Assisted
- Robotics